Physician profile
Patrick William Mclaughlin
NPI 1871685271
$8,443.63
in general payments reported to CMS, 2019-2025
7 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.36 · 2022: $4,565 · 2023: $3,601 · 2024: $85.59 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,550 · Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,550.00 |
| Food and Beverage | $312.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $7,504.73 | 2022-2023 | Cyberknife System |
| Bard Peripheral Vascular, INC. | $550.00 | 2023 | |
| Bioprotect Medical, INC. | $260.99 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $51.26 | 2023 | Spaceoar System |
| Gt Medical Technologies, INC | $39.83 | 2022 | |
| Elekta, INC. | $20.46 | 2022 | |
| Fortovia Therapeutics, INC. | $16.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mclaughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.